Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026
The global animal growth promoters and performance enhancers market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising animal epidemics and climate change. However, a ban on antibiotics in different nations and stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals are expected to restrain the growth of the animal growth promoters and performance enhancers market during the forecast period.
“The non-antibiotic growth promoters and performance enhancers segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”
The non-antibiotic growth promoters and performance enhancers segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2020. The large share of this segment can be attributed to the economic benefits of these products, the wide range of substances with applications in different production animals, environmental sustainability, and the increased number of regulations on antibiotics and hormones.
“Poultry segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”
Based on animal type, the poultry segment accounted for the largest share of the global animal growth promoters and performance enhancers market. The large market share of this segment can be attributed to the increasing demand for poultry meat and eggs, rising novel diet approaches, and increasing antibiotic phase-outs resulting in the development of alternatives.
“Asia Pacific to dominate the animal growth promoters and performance enhancers market during the forecast period”
Asia Pacific region accounted for the largest market share, followed by North America with a share in 2020. The large share of the Asia Pacific region can be attributed to the strong animal products industry in this region, huge population generating greater domestic meat demand, comparatively relaxed regulatory scenario, and government efforts to encourage animal producers.
A breakdown of the primary participants for the animal growth promoters and performance enhancers market referred to for this report is provided below:
Research Coverage:
The report analyzes the market for various animal growth promoters and performance enhancers and their adoption pattern. It aims at estimating the market size and future growth potential of the global animal growth promoters and performance enhancers market and different segments such as type, animal type and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
“The non-antibiotic growth promoters and performance enhancers segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”
The non-antibiotic growth promoters and performance enhancers segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2020. The large share of this segment can be attributed to the economic benefits of these products, the wide range of substances with applications in different production animals, environmental sustainability, and the increased number of regulations on antibiotics and hormones.
“Poultry segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”
Based on animal type, the poultry segment accounted for the largest share of the global animal growth promoters and performance enhancers market. The large market share of this segment can be attributed to the increasing demand for poultry meat and eggs, rising novel diet approaches, and increasing antibiotic phase-outs resulting in the development of alternatives.
“Asia Pacific to dominate the animal growth promoters and performance enhancers market during the forecast period”
Asia Pacific region accounted for the largest market share, followed by North America with a share in 2020. The large share of the Asia Pacific region can be attributed to the strong animal products industry in this region, huge population generating greater domestic meat demand, comparatively relaxed regulatory scenario, and government efforts to encourage animal producers.
A breakdown of the primary participants for the animal growth promoters and performance enhancers market referred to for this report is provided below:
- By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3–30%
- By Designation: C-level–27%, Director Level–18%, and Others–55%
- By Region: North America–50%, Europe–20%, Asia Pacific–15%, RoW- 15%
Research Coverage:
The report analyzes the market for various animal growth promoters and performance enhancers and their adoption pattern. It aims at estimating the market size and future growth potential of the global animal growth promoters and performance enhancers market and different segments such as type, animal type and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global animal growth promoters and performance enhancers market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global animal growth promoters and performance enhancers market
- Market Development: Comprehensive information on the lucrative emerging regions by type, animal type, and region
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global animal growth promoters and performance enhancers market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global animal growth promoters and performance enhancers market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET SEGMENTATION
FIGURE 2 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY REGION
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: ROYAL DSM N.V.
FIGURE 9 SUPPLY SIDE MARKET SIZE ESTIMATION: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR
FIGURE 11 CAGR PROJECTIONS
FIGURE 12 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
FIGURE 14 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET
4 PREMIUM INSIGHTS
4.1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET OVERVIEW
FIGURE 18 CONTINUOUS GROWTH IN THE GLOBAL MEAT DEMAND TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (2020)
FIGURE 19 NON-ANTIBIOTIC GROWTH PROMOTERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
FIGURE 20 EUROPEAN COUNTRIES TO WITNESS HIGH CAGR DURING
THE FORECAST PERIOD
4.4 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
REGIONAL MIX
FIGURE 21 ASIA PACIFIC IS THE LARGEST MARKET FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increase in demand and consumption of livestock-based products
TABLE 2 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS
FIGURE 23 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 24 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
5.2.1.2 Research for alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters
5.2.1.3 Rise in the global demand for naturally produced growth promoters
5.2.1.4 Rise in awareness about growth promoters
FIGURE 25 US: ANTIBIOTICS SALES (2018)
5.2.1.5 Rise in animal epidemics and climate change
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals
5.2.2.2 Ban on antibiotics in different nations
TABLE 3 BANS ON ANTIBIOTICS AND HORMONES, BY COUNTRY AND YEAR
5.2.3 OPPORTUNITIES
5.2.3.1 Focus on increasing environmental sustainability
5.2.4 CHALLENGES
5.2.4.1 Increasing global feed tonnage and high feed costs
leading to the adoption of conventional feeding systems
5.2.4.2 Growing threat of disease transmission to and from agricultural animals
6 INDUSTRY INSIGHTS
6.1 INDUSTRY TRENDS
6.1.1 INVESTMENT TOWARDS NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 4 INVESTMENT TOWARDS ANIMAL GROWTH PROMOTERS
6.1.2 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY
TABLE 5 MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY (2017–2019)
6.2 PRICING ANALYSIS
TABLE 6 AVERAGE SELLING PRICE OF ANIMAL GROWTH PROMOTERS
TABLE 7 SIMULATION OF THE ECONOMIC IMPACT OF REMOVING ANTIBIOTIC GROWTH PROMOTERS (AGP)
6.3 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.4 ECOSYSTEM MAPPING
FIGURE 27 ECOSYSTEM ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.5 SUPPLY CHAIN ANALYSIS
FIGURE 28 SUPPLY CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 PORTERS FIVE FORCES ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)
6.6.1 INTENSITY OF COMPETITIVE RIVALRY
6.6.2 BARGAINING POWER OF SUPPLIERS
6.6.3 BARGAINING POWER OF BUYERS
6.6.4 THREAT OF NEW ENTRANTS
6.6.5 THREAT OF SUBSTITUTES
6.7 REGULATORY ANALYSIS
FIGURE 29 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
FIGURE 30 APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS IN EUROPE
6.8 PATENT ANALYSIS
6.8.1 PATENT PUBLICATION TRENDS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
FIGURE 31 GLOBAL PATENT PUBLICATION TRENDS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, 2015–2020
6.9 TRADE ANALYSIS
TABLE 9 IMPORT SHIPMENT RELATED TO ANIMAL GROWTH PROMOTERS
6.10 IMPACT OF THE COVID-19 PANDEMIC ON THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE
ENHANCERS MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 10 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
7.2 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 11 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 12 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 PREBIOTICS & PROBIOTICS
7.2.1.1 Prebiotics & probiotics hold the largest share of the market
TABLE 13 PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 ACIDIFIERS
7.2.2.1 Regulations on antibiotics and wide applications in different production animals to drive the use of acidifiers
TABLE 14 ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 PHYTOGENICS
7.2.3.1 Natural performance enhancement and antioxidative & disease defense properties to support the use of phytogenics
TABLE 15 PHYTOGENICS GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 FEED ENZYMES
7.2.4.1 Feed enzymes segment to benefit from the bans on antibiotics and hormones
TABLE 16 FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 HORMONES
7.2.5.1 Human health implications and restricted usage due to regulations to hamper the growth of the hormones segment
TABLE 17 HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.6 OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 18 OTHER NON-ANTIBIOTIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 ANTIBIOTIC GROWTH PROMOTERS
7.3.1 ANTIBIOTIC GROWTH PROMOTERS TO FACE A GRADUAL DECLINE DUE TO UNFAVORABLE REGULATIONS AND BANS
TABLE 19 PERCENTAGE SALES OF ANTIMICROBIAL SUBSTANCES IN THE US (2019)
TABLE 20 ANTIBIOTICS BANS AND REGULATIONS, BY COUNTRY
TABLE 21 ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
TABLE 22 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
8.2 POULTRY
8.2.1 THE POULTRY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2020
TABLE 23 IMPORTANT STATISTICS RELATED TO POULTRY MEAT (2020)
TABLE 24 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 LIVESTOCK
8.3.1 THE LIVESTOCK SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
TABLE 25 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR LIVESTOCK, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 SWINE
8.4.1 RISING DEMAND FOR PORK MEAT AND THE INCREASING AWARENESS OF AFRICAN SWINE FEVER (ASF) OUTBREAK TO DRIVE THE ADOPTION OF GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 26 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR SWINE, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 AQUATIC ANIMALS
8.5.1 GROWING PRODUCTION AND CONSUMPTION OF SEAFOOD TO DRIVE THE DEMAND FOR GROWTH PROMOTERS
TABLE 27 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
8.6 OTHER ANIMALS
TABLE 28 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
9 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 32 ASIA PACIFIC WILL DOMINATE THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET DURING THE FORECAST PERIOD
TABLE 29 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT
TABLE 30 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 31 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 32 ASIA PACIFIC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 33 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.1 CHINA
9.2.1.1 China to dominate the APAC animal growth promoters and performance enhancers market
TABLE 34 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 35 CHINA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 36 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.2 INDIA
9.2.2.1 Large livestock population and increased production and export capacities to drive market growth
TABLE 37 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 INDIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 39 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.3 JAPAN
9.2.3.1 Rising domestic meat demand and government efforts to encourage animal producers to drive the demand for growth promoters in Japan
TABLE 40 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 41 JAPAN: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 42 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.4 AUSTRALIA
9.2.4.1 Large cattle population and heavy meat exports to support the market in Australia
TABLE 43 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 44 AUSTRALIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 45 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.5 REST OF ASIA PACIFIC
9.2.5.1 Lack of a defined regulatory scenario to result in the wide use of antibiotic growth promoters in the RoAPAC
TABLE 46 REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY
TABLE 47 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 48 ROAPAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 49 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.3 NORTH AMERICA
TABLE 50 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 52 NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.3.1 US
9.3.1.1 Increasing meat consumption to drive the market in the US
FIGURE 34 US: GROWTH IN BEEF CONSUMPTION, 2014–2019 (BILLION POUNDS)
TABLE 54 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 55 US: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.3.2 CANADA
9.3.2.1 Production and export of meat and aquaculture in Canada to drive the market growth
TABLE 57 BEEF AND VEAL EXPORTS BY CANADA BETWEEN OCTOBER 2018 AND OCTOBER 2019
TABLE 58 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 59 CANADA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4 EUROPE
FIGURE 35 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT
TABLE 61 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.1 UK
9.4.1.1 Preventive measures to avoid the risk of zoonotic diseases to drive the market in the UK
TABLE 65 UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 UK: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.2 GERMANY
9.4.2.1 Increasing veterinary visits and growing healthcare expenditure to boost the growth of the market in Germany
FIGURE 36 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011 TO 2018)
TABLE 68 GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.3 SWITZERLAND
9.4.3.1 Increasing milk demand to drive the market in Switzerland
TABLE 71 SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 SWITZERLAND: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.4 RUSSIA
9.4.4.1 Russia to hold the largest share of the European market due to its large poultry production
TABLE 74 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 75 RUSSIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.5 REST OF EUROPE
9.4.5.1 Technological advancements and the strong trade industry to support the RoE market
TABLE 77 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 ROE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 79 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 80 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 81 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 LATIN AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 83 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil to dominate the Latin American market for animal growth promoters and performance enhancers
TABLE 84 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 BRAZIL: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.5.2 REST OF LATIN AMERICA
9.5.2.1 Strong demand for animal products and support initiatives to help the market in the RoLA
TABLE 87 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 ROLA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST
9.6.1 INCREASING DEMAND FOR CHICKEN AND SEAFOOD TO CONTRIBUTE TO MARKET GROWTH IN THE MIDDLE EAST
TABLE 90 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 MIDDLE EAST: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.7 AFRICA
9.7.1 RELIANCE ON CONVENTIONAL LIVESTOCK PRODUCTION PRACTICES TO HAMPER THE MARKET GROWTH IN AFRICA
TABLE 93 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 AFRICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
FIGURE 37 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)
10.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
10.3 MARKET SHARE ANALYSIS
FIGURE 39 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2020
10.4 COMPETITIVE SCENARIO
10.4.1 PRODUCT LAUNCHES
TABLE 96 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: PRODUCT LAUNCHES (JANUARY 2018 TO AUGUST 2021)
10.4.2 DEALS
TABLE 97 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DEALS (JANUARY 2018 TO AUGUST 2021)
10.4.3 OTHER DEVELOPMENTS
TABLE 98 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)
10.5 COMPETITIVE BENCHMARKING
10.5.1 COMPANY FOOTPRINT FOR KEY PLAYERS
10.5.2 PRODUCT TYPE FOOTPRINT OF COMPANIES
10.5.3 ANIMAL TYPE FOOTPRINT OF COMPANIES
10.5.4 REGIONAL FOOTPRINT OF COMPANIES
10.6 GEOGRAPHIC FOOTPRINT OF COMPANIES
10.6.1 GEOGRAPHIC REVENUE MIX: KEY PLAYERS
10.7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
R&D EXPENDITURE
10.7.1 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2019 VS. 2020)
10.8 COMPANY EVALUATION MATRIX
10.8.1 STARS
10.8.2 EMERGING LEADERS
10.8.3 PERVASIVE PLAYERS
10.8.4 EMERGING COMPANIES
FIGURE 40 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: GLOBAL COMPANY EVALUATION MATRIX
10.9 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
10.9.1 PROGRESSIVE COMPANIES
10.9.2 STARTING BLOCKS
10.9.3 RESPONSIVE COMPANIES
10.9.4 DYNAMIC COMPANIES
FIGURE 41 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 CARGILL, INCORPORATED
TABLE 99 CARGILL, INCORPORATED: BUSINESS OVERVIEW
11.1.2 ROYAL DSM N.V.
TABLE 100 ROYAL DSM N.V.: BUSINESS OVERVIEW
FIGURE 42 COMPANY SNAPSHOT: ROYAL DSM N.V. (2020)
11.1.3 ELANCO ANIMAL HEALTH INCORPORATED
TABLE 101 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW
FIGURE 43 COMPANY SNAPSHOT: ELANCO ANIMAL HEALTH INCORPORATED (2020)
11.1.4 BOEHRINGER INGELHEIM GROUP
TABLE 102 BOEHRINGER INGELHEIM GROUP: BUSINESS OVERVIEW
FIGURE 44 COMPANY SNAPSHOT: BOEHRINGER INGELHEIM GROUP (2020)
11.1.5 MERCK & CO., INC.
TABLE 103 MERCK & CO., INC.: BUSINESS OVERVIEW
FIGURE 45 COMPANY SNAPSHOT: MERCK & CO., INC. (2020)
11.1.6 ARCHER-DANIELS-MIDLAND COMPANY (ADM)
TABLE 104 ARCHER-DANIELS-MIDLAND COMPANY: BUSINESS OVERVIEW
FIGURE 46 COMPANY SNAPSHOT: ARCHER-DANIELS-MIDLAND COMPANY (2020)
11.1.7 BLUESTAR ADISSEO COMPANY
TABLE 105 BLUESTAR ADISSEO COMPANY: BUSINESS OVERVIEW
FIGURE 47 COMPANY SNAPSHOT: BLUESTAR ADISSEO COMPANY (2020)
11.1.8 ALLTECH CORPORATION
TABLE 106 ALLTECH CORPORATION: BUSINESS OVERVIEW
11.1.9 EVONIK INDUSTRIES AG
TABLE 107 EVONIK INDUSTRIES AG: BUSINESS OVERVIEW
FIGURE 48 COMPANY SNAPSHOT: EVONIK INDUSTRIES AG (2020)
11.1.10 VETOQUINOL S.A.
TABLE 108 VETOQUINOL S.A.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 BUPO ANIMAL HEALTH PTY LTD.
TABLE 109 BUPO ANIMAL HEALTH PTY LTD: BUSINESS OVERVIEW
11.2.2 NOVUS INTERNATIONAL, INC.
TABLE 110 NOVUS INTERNATIONAL, INC.: BUSINESS OVERVIEW
11.2.3 ASSOCIATED BRITISH FOODS PLC
TABLE 111 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
FIGURE 49 COMPANY SNAPSHOT: ASSOCIATED BRITISH FOODS PLC (2020)
11.2.4 ERBER AG
TABLE 112 ERBER AG: BUSINESS OVERVIEW
11.2.5 PHIBRO ANIMAL HEALTH CORPORATION
TABLE 113 PHIBRO ANIMAL HEALTH CORPORATION: BUSINESS OVERVIEW
FIGURE 50 COMPANY SNAPSHOT: PHIBRO ANIMAL HEALTH CORPORATION (2020)
11.2.6 KEMIN INDUSTRIES, INC.
TABLE 114 KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW
11.2.7 ZOETIS INC.
TABLE 115 ZOETIS INC.: BUSINESS OVERVIEW
FIGURE 51 COMPANY SNAPSHOT: ZOETIS INC. (2020)
11.2.8 NUTRECO N.V. (A WHOLLY-OWNED SUBSIDIARY OF SHV GROUP)
TABLE 116 NUTRECO N.V.: BUSINESS OVERVIEW
FIGURE 52 COMPANY SNAPSHOT: SHV GROUP (2020)
11.2.9 NOVOZYMES A/S
TABLE 117 NOVOZYMES A/S.: BUSINESS OVERVIEW
FIGURE 53 COMPANY SNAPSHOT: NOVOZYMES A/S (2020)
11.2.10 BASF SE
TABLE 118 BASF SE: BUSINESS OVERVIEW
FIGURE 54 COMPANY SNAPSHOT: BASF SE (2020)
11.2.11 LAND O’LAKES, INC.
11.2.12 CHR. HANSEN A/S
11.2.13 BIOMIN HOLDING GMBH
11.2.14 GUANGDONG VTR BIO-TECH CO., LTD.
11.2.15 LALLEMAND INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET SEGMENTATION
FIGURE 2 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY REGION
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: ROYAL DSM N.V.
FIGURE 9 SUPPLY SIDE MARKET SIZE ESTIMATION: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR
FIGURE 11 CAGR PROJECTIONS
FIGURE 12 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
FIGURE 14 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET
4 PREMIUM INSIGHTS
4.1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET OVERVIEW
FIGURE 18 CONTINUOUS GROWTH IN THE GLOBAL MEAT DEMAND TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (2020)
FIGURE 19 NON-ANTIBIOTIC GROWTH PROMOTERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
FIGURE 20 EUROPEAN COUNTRIES TO WITNESS HIGH CAGR DURING
THE FORECAST PERIOD
4.4 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
REGIONAL MIX
FIGURE 21 ASIA PACIFIC IS THE LARGEST MARKET FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increase in demand and consumption of livestock-based products
TABLE 2 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS
FIGURE 23 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 24 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
5.2.1.2 Research for alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters
5.2.1.3 Rise in the global demand for naturally produced growth promoters
5.2.1.4 Rise in awareness about growth promoters
FIGURE 25 US: ANTIBIOTICS SALES (2018)
5.2.1.5 Rise in animal epidemics and climate change
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals
5.2.2.2 Ban on antibiotics in different nations
TABLE 3 BANS ON ANTIBIOTICS AND HORMONES, BY COUNTRY AND YEAR
5.2.3 OPPORTUNITIES
5.2.3.1 Focus on increasing environmental sustainability
5.2.4 CHALLENGES
5.2.4.1 Increasing global feed tonnage and high feed costs
leading to the adoption of conventional feeding systems
5.2.4.2 Growing threat of disease transmission to and from agricultural animals
6 INDUSTRY INSIGHTS
6.1 INDUSTRY TRENDS
6.1.1 INVESTMENT TOWARDS NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 4 INVESTMENT TOWARDS ANIMAL GROWTH PROMOTERS
6.1.2 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY
TABLE 5 MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY (2017–2019)
6.2 PRICING ANALYSIS
TABLE 6 AVERAGE SELLING PRICE OF ANIMAL GROWTH PROMOTERS
TABLE 7 SIMULATION OF THE ECONOMIC IMPACT OF REMOVING ANTIBIOTIC GROWTH PROMOTERS (AGP)
6.3 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.4 ECOSYSTEM MAPPING
FIGURE 27 ECOSYSTEM ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.5 SUPPLY CHAIN ANALYSIS
FIGURE 28 SUPPLY CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 PORTERS FIVE FORCES ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)
6.6.1 INTENSITY OF COMPETITIVE RIVALRY
6.6.2 BARGAINING POWER OF SUPPLIERS
6.6.3 BARGAINING POWER OF BUYERS
6.6.4 THREAT OF NEW ENTRANTS
6.6.5 THREAT OF SUBSTITUTES
6.7 REGULATORY ANALYSIS
FIGURE 29 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
FIGURE 30 APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS IN EUROPE
6.8 PATENT ANALYSIS
6.8.1 PATENT PUBLICATION TRENDS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
FIGURE 31 GLOBAL PATENT PUBLICATION TRENDS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, 2015–2020
6.9 TRADE ANALYSIS
TABLE 9 IMPORT SHIPMENT RELATED TO ANIMAL GROWTH PROMOTERS
6.10 IMPACT OF THE COVID-19 PANDEMIC ON THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE
ENHANCERS MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 10 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
7.2 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 11 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 12 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 PREBIOTICS & PROBIOTICS
7.2.1.1 Prebiotics & probiotics hold the largest share of the market
TABLE 13 PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 ACIDIFIERS
7.2.2.1 Regulations on antibiotics and wide applications in different production animals to drive the use of acidifiers
TABLE 14 ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 PHYTOGENICS
7.2.3.1 Natural performance enhancement and antioxidative & disease defense properties to support the use of phytogenics
TABLE 15 PHYTOGENICS GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 FEED ENZYMES
7.2.4.1 Feed enzymes segment to benefit from the bans on antibiotics and hormones
TABLE 16 FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 HORMONES
7.2.5.1 Human health implications and restricted usage due to regulations to hamper the growth of the hormones segment
TABLE 17 HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.6 OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 18 OTHER NON-ANTIBIOTIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 ANTIBIOTIC GROWTH PROMOTERS
7.3.1 ANTIBIOTIC GROWTH PROMOTERS TO FACE A GRADUAL DECLINE DUE TO UNFAVORABLE REGULATIONS AND BANS
TABLE 19 PERCENTAGE SALES OF ANTIMICROBIAL SUBSTANCES IN THE US (2019)
TABLE 20 ANTIBIOTICS BANS AND REGULATIONS, BY COUNTRY
TABLE 21 ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
TABLE 22 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
8.2 POULTRY
8.2.1 THE POULTRY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2020
TABLE 23 IMPORTANT STATISTICS RELATED TO POULTRY MEAT (2020)
TABLE 24 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 LIVESTOCK
8.3.1 THE LIVESTOCK SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
TABLE 25 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR LIVESTOCK, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 SWINE
8.4.1 RISING DEMAND FOR PORK MEAT AND THE INCREASING AWARENESS OF AFRICAN SWINE FEVER (ASF) OUTBREAK TO DRIVE THE ADOPTION OF GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 26 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR SWINE, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 AQUATIC ANIMALS
8.5.1 GROWING PRODUCTION AND CONSUMPTION OF SEAFOOD TO DRIVE THE DEMAND FOR GROWTH PROMOTERS
TABLE 27 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
8.6 OTHER ANIMALS
TABLE 28 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
9 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 32 ASIA PACIFIC WILL DOMINATE THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET DURING THE FORECAST PERIOD
TABLE 29 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT
TABLE 30 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 31 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 32 ASIA PACIFIC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 33 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.1 CHINA
9.2.1.1 China to dominate the APAC animal growth promoters and performance enhancers market
TABLE 34 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 35 CHINA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 36 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.2 INDIA
9.2.2.1 Large livestock population and increased production and export capacities to drive market growth
TABLE 37 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 INDIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 39 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.3 JAPAN
9.2.3.1 Rising domestic meat demand and government efforts to encourage animal producers to drive the demand for growth promoters in Japan
TABLE 40 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 41 JAPAN: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 42 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.4 AUSTRALIA
9.2.4.1 Large cattle population and heavy meat exports to support the market in Australia
TABLE 43 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 44 AUSTRALIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 45 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.2.5 REST OF ASIA PACIFIC
9.2.5.1 Lack of a defined regulatory scenario to result in the wide use of antibiotic growth promoters in the RoAPAC
TABLE 46 REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY
TABLE 47 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 48 ROAPAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 49 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.3 NORTH AMERICA
TABLE 50 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 52 NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.3.1 US
9.3.1.1 Increasing meat consumption to drive the market in the US
FIGURE 34 US: GROWTH IN BEEF CONSUMPTION, 2014–2019 (BILLION POUNDS)
TABLE 54 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 55 US: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.3.2 CANADA
9.3.2.1 Production and export of meat and aquaculture in Canada to drive the market growth
TABLE 57 BEEF AND VEAL EXPORTS BY CANADA BETWEEN OCTOBER 2018 AND OCTOBER 2019
TABLE 58 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 59 CANADA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4 EUROPE
FIGURE 35 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT
TABLE 61 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.1 UK
9.4.1.1 Preventive measures to avoid the risk of zoonotic diseases to drive the market in the UK
TABLE 65 UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 UK: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.2 GERMANY
9.4.2.1 Increasing veterinary visits and growing healthcare expenditure to boost the growth of the market in Germany
FIGURE 36 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011 TO 2018)
TABLE 68 GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.3 SWITZERLAND
9.4.3.1 Increasing milk demand to drive the market in Switzerland
TABLE 71 SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 SWITZERLAND: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.4 RUSSIA
9.4.4.1 Russia to hold the largest share of the European market due to its large poultry production
TABLE 74 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 75 RUSSIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.4.5 REST OF EUROPE
9.4.5.1 Technological advancements and the strong trade industry to support the RoE market
TABLE 77 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 ROE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 79 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 80 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 81 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 LATIN AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 83 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil to dominate the Latin American market for animal growth promoters and performance enhancers
TABLE 84 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 BRAZIL: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.5.2 REST OF LATIN AMERICA
9.5.2.1 Strong demand for animal products and support initiatives to help the market in the RoLA
TABLE 87 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 ROLA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST
9.6.1 INCREASING DEMAND FOR CHICKEN AND SEAFOOD TO CONTRIBUTE TO MARKET GROWTH IN THE MIDDLE EAST
TABLE 90 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 MIDDLE EAST: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
9.7 AFRICA
9.7.1 RELIANCE ON CONVENTIONAL LIVESTOCK PRODUCTION PRACTICES TO HAMPER THE MARKET GROWTH IN AFRICA
TABLE 93 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 AFRICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
FIGURE 37 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)
10.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
10.3 MARKET SHARE ANALYSIS
FIGURE 39 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2020
10.4 COMPETITIVE SCENARIO
10.4.1 PRODUCT LAUNCHES
TABLE 96 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: PRODUCT LAUNCHES (JANUARY 2018 TO AUGUST 2021)
10.4.2 DEALS
TABLE 97 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DEALS (JANUARY 2018 TO AUGUST 2021)
10.4.3 OTHER DEVELOPMENTS
TABLE 98 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)
10.5 COMPETITIVE BENCHMARKING
10.5.1 COMPANY FOOTPRINT FOR KEY PLAYERS
10.5.2 PRODUCT TYPE FOOTPRINT OF COMPANIES
10.5.3 ANIMAL TYPE FOOTPRINT OF COMPANIES
10.5.4 REGIONAL FOOTPRINT OF COMPANIES
10.6 GEOGRAPHIC FOOTPRINT OF COMPANIES
10.6.1 GEOGRAPHIC REVENUE MIX: KEY PLAYERS
10.7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
R&D EXPENDITURE
10.7.1 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2019 VS. 2020)
10.8 COMPANY EVALUATION MATRIX
10.8.1 STARS
10.8.2 EMERGING LEADERS
10.8.3 PERVASIVE PLAYERS
10.8.4 EMERGING COMPANIES
FIGURE 40 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: GLOBAL COMPANY EVALUATION MATRIX
10.9 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
10.9.1 PROGRESSIVE COMPANIES
10.9.2 STARTING BLOCKS
10.9.3 RESPONSIVE COMPANIES
10.9.4 DYNAMIC COMPANIES
FIGURE 41 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 CARGILL, INCORPORATED
TABLE 99 CARGILL, INCORPORATED: BUSINESS OVERVIEW
11.1.2 ROYAL DSM N.V.
TABLE 100 ROYAL DSM N.V.: BUSINESS OVERVIEW
FIGURE 42 COMPANY SNAPSHOT: ROYAL DSM N.V. (2020)
11.1.3 ELANCO ANIMAL HEALTH INCORPORATED
TABLE 101 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW
FIGURE 43 COMPANY SNAPSHOT: ELANCO ANIMAL HEALTH INCORPORATED (2020)
11.1.4 BOEHRINGER INGELHEIM GROUP
TABLE 102 BOEHRINGER INGELHEIM GROUP: BUSINESS OVERVIEW
FIGURE 44 COMPANY SNAPSHOT: BOEHRINGER INGELHEIM GROUP (2020)
11.1.5 MERCK & CO., INC.
TABLE 103 MERCK & CO., INC.: BUSINESS OVERVIEW
FIGURE 45 COMPANY SNAPSHOT: MERCK & CO., INC. (2020)
11.1.6 ARCHER-DANIELS-MIDLAND COMPANY (ADM)
TABLE 104 ARCHER-DANIELS-MIDLAND COMPANY: BUSINESS OVERVIEW
FIGURE 46 COMPANY SNAPSHOT: ARCHER-DANIELS-MIDLAND COMPANY (2020)
11.1.7 BLUESTAR ADISSEO COMPANY
TABLE 105 BLUESTAR ADISSEO COMPANY: BUSINESS OVERVIEW
FIGURE 47 COMPANY SNAPSHOT: BLUESTAR ADISSEO COMPANY (2020)
11.1.8 ALLTECH CORPORATION
TABLE 106 ALLTECH CORPORATION: BUSINESS OVERVIEW
11.1.9 EVONIK INDUSTRIES AG
TABLE 107 EVONIK INDUSTRIES AG: BUSINESS OVERVIEW
FIGURE 48 COMPANY SNAPSHOT: EVONIK INDUSTRIES AG (2020)
11.1.10 VETOQUINOL S.A.
TABLE 108 VETOQUINOL S.A.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 BUPO ANIMAL HEALTH PTY LTD.
TABLE 109 BUPO ANIMAL HEALTH PTY LTD: BUSINESS OVERVIEW
11.2.2 NOVUS INTERNATIONAL, INC.
TABLE 110 NOVUS INTERNATIONAL, INC.: BUSINESS OVERVIEW
11.2.3 ASSOCIATED BRITISH FOODS PLC
TABLE 111 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
FIGURE 49 COMPANY SNAPSHOT: ASSOCIATED BRITISH FOODS PLC (2020)
11.2.4 ERBER AG
TABLE 112 ERBER AG: BUSINESS OVERVIEW
11.2.5 PHIBRO ANIMAL HEALTH CORPORATION
TABLE 113 PHIBRO ANIMAL HEALTH CORPORATION: BUSINESS OVERVIEW
FIGURE 50 COMPANY SNAPSHOT: PHIBRO ANIMAL HEALTH CORPORATION (2020)
11.2.6 KEMIN INDUSTRIES, INC.
TABLE 114 KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW
11.2.7 ZOETIS INC.
TABLE 115 ZOETIS INC.: BUSINESS OVERVIEW
FIGURE 51 COMPANY SNAPSHOT: ZOETIS INC. (2020)
11.2.8 NUTRECO N.V. (A WHOLLY-OWNED SUBSIDIARY OF SHV GROUP)
TABLE 116 NUTRECO N.V.: BUSINESS OVERVIEW
FIGURE 52 COMPANY SNAPSHOT: SHV GROUP (2020)
11.2.9 NOVOZYMES A/S
TABLE 117 NOVOZYMES A/S.: BUSINESS OVERVIEW
FIGURE 53 COMPANY SNAPSHOT: NOVOZYMES A/S (2020)
11.2.10 BASF SE
TABLE 118 BASF SE: BUSINESS OVERVIEW
FIGURE 54 COMPANY SNAPSHOT: BASF SE (2020)
11.2.11 LAND O’LAKES, INC.
11.2.12 CHR. HANSEN A/S
11.2.13 BIOMIN HOLDING GMBH
11.2.14 GUANGDONG VTR BIO-TECH CO., LTD.
11.2.15 LALLEMAND INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
